Company Profile
Fresenius Medical Care Ventures Stock Price, News & Analysis
- Ticker:
- FMS
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- Germany and listed in the U
Stock performance
24.10 USD (+0.88%)
Close
Last updated: August 6, 2026
11B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, FMS closed up 0.88% at $24.10. No new same-company headline was identified in the current news window.
Company overview
Business overview
Fresenius Medical Care is a global dialysis and kidney-care company focused on renal services, dialysis products, and related healthcare infrastructure. Its business is built around treating chronic kidney disease at scale.
Geographic Base and Sector Classification
Headquartered in Germany and listed in the U.S. as an ADR, Fresenius Medical Care has a global operating footprint. It sits in healthcare services and dialysis, not biotechnology.
Business Model Characteristics
The company generates revenue through dialysis treatments, care services, and medical products used in renal care. Investors focus on reimbursement, patient volume, treatment economics, and operational efficiency.
Position Within the Biotechnology Landscape
Fresenius Medical Care is not a biotech name, but it matters to healthcare investors because it sits in a critical chronic-care segment. Its stock is driven by utilization and reimbursement rather than trial data.
Future catalysts
Fresenius Medical Care’s catalysts are dialysis margin recovery, care-delivery efficiency, and any update on the turnaround plan. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.
Recent news
- 01
Fresenius Medical Care accelerates income growth to 23% in the second quarter of 2026 while advancing its strategic agenda
Source: Fresenius Medical Care Ventures
- 02
Fresenius Medical Care appoints Cassie McLean as new Management Board Member for Care Delivery
Source: Fresenius Medical Care Ventures
- 03
Fresenius Medical Care announces BEACON-US, generating real-world evidence supporting high-volume hemodiafiltration for U.S. dialysis patients
Source: Fresenius Medical Care Ventures
- 04
Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy
Source: Fresenius Medical Care Ventures
- 05
Interwell Health Delivers Strong Quality Scores and Shared Savings in CMS Value-Based Kidney Care Model
Source: Fresenius Medical Care Ventures
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Fresenius Medical Care Ventures (FMS)?
Fresenius Medical Care Ventures (FMS) most recently closed at 24.10 USD, a +0.88% move versus the previous session.
What is the market cap of Fresenius Medical Care Ventures (FMS)?
Fresenius Medical Care Ventures currently has a market capitalization of 11B USD on BioPharmSignal.
What does Fresenius Medical Care Ventures do?
Fresenius Medical Care is a global dialysis and kidney-care company focused on renal services, dialysis products, and related healthcare infrastructure. Its business is built around treating chronic kidney disease at scale.
On which exchange is FMS stock listed?
Fresenius Medical Care Ventures (FMS) is associated with NYSE, Germany and listed in the U, Biopharma.
What is Fresenius?
Fresenius Medical Care’s catalysts are dialysis margin recovery, care-delivery efficiency, and any update on the turnaround plan.
Which conditions is Fresenius Medical Care Ventures targeting with Fresenius?
Fresenius Medical Care’s catalysts are dialysis margin recovery, care-delivery efficiency, and any update on the turnaround plan.
How does Fresenius Medical Care Ventures describe recent progress with Fresenius?
Fresenius Medical Care’s catalysts are dialysis margin recovery, care-delivery efficiency, and any update on the turnaround plan.
What is Medical?
Fresenius Medical Care is a global dialysis and kidney-care company focused on renal services, dialysis products, and related healthcare infrastructure.